prescribing safety assessment MCQ (SBA): Hepatitis C Pharmacology

Instant feedback + full explanation. One question, done properly.

HardInfectious DiseasesHepatitis C Pharmacologyprescribing safety assessmentmrcp part 1

A 58-year-old man with chronic HCV is starting sofosbuvir/velpatasvir. Which common PPI interaction advice is correct?

Educational content. Not a substitute for clinical judgement or local policy.

prescribing safety assessment MCQ: Hepatitis C Pharmacology — Answer &